Sinphar Pharmaceutical Co.,Ltd. Stocks

Sinphar Pharmaceutical Co.,Ltd., operating both domestically in Taiwan and internationally through its subsidiaries, is actively engaged in the research, development, production, and distribution of a wide array of therapeutic medicines, health supplements, and medical-grade beauty products. Its extensive pharmaceutical line includes specialized anti-cancer treatments, presented as injections, solid reagents, and hormone compounds. The company also manufactures various other dosage forms, such as tablets, soft gel capsules, and nutritional products available in powdered or canned formats. Beyond pharmaceuticals, Sinphar offers a diverse collection of personal care and cosmetic items, encompassing shampoos, body washes, toners, lotions, moisturizers, sunscreen lotions, and serums. The company further contributes to the industry by producing essential pharmaceutical packaging, including bottles for eye drops, desiccant canisters, tablet containers, and a range of other medical-grade plastic vessels. Moreover, Sinphar develops plant-derived extracts and functional foods, and provides comprehensive OEM (Original Equipment Manufacturer) services to other businesses, covering everything from initial product design to final manufacturing. The company, established in 1977, is headquartered in Yilan City, Taiwan.